concept

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about : its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1682Connections
30Hypotheses
13Analyses
50Outgoing
50Incoming
0Experiments
20Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info
Name
Key Genes/ProteinsAB, ABCA1, ACHE, AD

Pathway Diagram

graph TD
    A_[AΒ]
    A_ -->|causes| Neurodegeneration[Neurodegeneration]
    A_ -->|causes| Alzheimer_s_Disease[Alzheimer's Disease]
    A_ -->|involved_in| Protein_Assembly[Protein Assembly]
    A_ -.biomarker for.-> Biomarker_For_Alzheimer_s_Dise[Biomarker For Alzheimer's Disease]
    A_ -->|involved_in| Synapse_Pathology[Synapse Pathology]
    A_ -->|causes| neuronal_death[neuronal death]
    A_ -->|implicated in| Alzheimer_disease[Alzheimer disease]
    A_ -->|induces| IFN_[IFNγ]
    A_ -->|drives_formation_of| lipid_rafts[lipid rafts]
    A_ -->|causes| Oxidative_stress[Oxidative stress]
    APP[APP] -->|product_of| A_
    L1CAM[L1CAM] -->|binds| A_
    APOE__2_ISOFORM[APOE Ε2 ISOFORM] -->|interacts| A_
    SV2A[SV2A] -->|correlates_with| A_
    AUTOPHAGY[AUTOPHAGY] -->|mediates| A_
    APOE__2[APOE Ε2] -->|interacts| A_
    SQSTM1[SQSTM1] -->|involved_in| A_

Outgoing (826)

TargetRelationTypeStr
Alzheimer's Diseasecausesdisease0.95
Neurodegenerationcausesprocess0.95
Autophagyassociated_withprocess0.95
Endo-lysosomal systemassociated_withorganelle0.95
PV+ interneuronsinhibitscell_type0.90

Incoming (856)

SourceRelationTypeStr
34456336is a promising target forpaper0.90
26010513impairspaper0.90
26137544begins to accumulate withinpaper0.90
26739002induces spreading ofpaper0.90
40649980suppressespaper0.90

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Multi-Target Hypothesis: Aβ-Induced Cholinergic Damage is Pa 0.887 - Do β-amyloid plaques and neurofibrillary
ω-3 Docosahexaenoic Acid (DHA) Epoxide Generation via CYP2J2 0.802 lipidomics Lipid metabolism dysregulation in Alzhei
Closed-loop focused ultrasound targeting CA1 PV interneurons 0.754 alzheimers Circuit-level neural dynamics in neurode
Tau missorting transitions into an autonomous tau-seeding st 0.740 neurodegeneration Does tau dendritic missorting persist in
Microglia and complement sustain post-Aβ neurodegeneration a 0.690 neurodegeneration Does tau dendritic missorting persist in
ISR/eIF2α~P Overflow Represses Synaptic Protein Synthesis Do 0.683 alzheimers -
Soluble LRP1 (sLRP1) Ectodomain Shedding as a Blood-Based In 0.680 - What blood-brain barrier permeability ch
Gamma entrainment enhances TREM2-mediated microglial clearan 0.678 alzheimers Gamma entrainment therapy to restore hip
Fyn-anchored dendritic tau/NMDAR signaling persists after tr 0.670 neurodegeneration Does tau dendritic missorting persist in
PDGF-BB/PDGFRβ/STAT3 Paracrine Signaling Axis Mediates Aβ-In 0.618 neurodegeneration How do perivascular cells specifically r
LRP1/NLRP3/IL-1β Cascade Links Aβ Endocytosis to Inflammasom 0.617 neurodegeneration How do perivascular cells specifically r
Aβ42 oligomers drive TDP-43 phosphorylation at s409/410 thro 0.595 neurodegeneration What mechanisms drive TDP-43 pathology s
Aβ-induced downregulation of circPDS5B derepresses TDP-43 mR 0.595 neurodegeneration What mechanisms drive TDP-43 pathology s
Closed-Loop Phase-Specific Targeting of PV-to-Pyramidal Syna 0.585 alzheimers Closed-loop optogenetic targeting PV int
Neuropeptide Y (NPY) Co-release from PV Interneurons Modulat 0.585 alzheimers Closed-loop optogenetic targeting PV int
Astrocyte-PV Interneuron Metabolic Coupling as a Mediator of 0.565 alzheimers Closed-loop optogenetic targeting PV int
HBOT (2.0 ATA, 60 min) activates TFEB-mediated autophagy-lys 0.560 neurodegeneration What are the optimal oxygen pressure, du
CYP46A1 Activation as a Therapeutic Strategy to Restore Neur 0.550 lipidomics Lipid metabolism dysregulation in Alzhei
Cross-Seeding: Gut Microbiome-Derived Bacterial Curli and Fu 0.540 neurodegeneration How does gut microbiome dysbiosis contri
CD36 Acts as Primary Aβ Oligomer Sensor on Perivascular Macr 0.535 neurodegeneration How do perivascular cells specifically r
Epigenetic CRISPR/dCas9 Activation of PV Gene Program Preven 0.525 alzheimers Closed-loop optogenetic targeting PV int
TREM2 on Perivascular Macrophages Senses Aβ and Drives SPP1 0.496 neurodegeneration How do perivascular cells specifically r
Reactive astrocyte glutamate-handling failure sustains dendr 0.490 neurodegeneration Does tau dendritic missorting persist in
Soluble LRP1 Fragments Serve as Blood-Based Indicators of Im 0.485 - What blood-brain barrier permeability ch
BIN1-dependent trafficking defects determine whether post-Aβ 0.460 neurodegeneration Does tau dendritic missorting persist in
GM1 Ganglioside Reduction via ST3GAL5 Activation to Block Aβ 0.454 lipidomics Lipid metabolism dysregulation in Alzhei
RAGE/STAT3/IL-6 Autocrine Loop Mediates Aβ-Induced SPP1 Upre 0.442 neurodegeneration How do perivascular cells specifically r
P2X7/P2Y12 Purinergic Signaling Connects Aβ Aggregation to S 0.423 neurodegeneration How do perivascular cells specifically r
CYP2J2-Derived DHA Epoxides Modulate Microglial M2 Polarizat 0.380 lipidomics Lipid metabolism dysregulation in Alzhei
Personalized Microbiome Restoration Based on Individual Aβ C 0.000 - Gut-Brain Axis Therapeutics for Alzheime

Mentioning Analyses (13)

Scientific analyses that reference this entity

What blood-brain barrier permeability changes serve as early biomarkers for neur

neurodegeneration | 2026-04-26 | 8 hypotheses Top: 0.735

TREM2 in Alzheimer's Disease: Mechanisms, Therapeutics, and Biomarkers

neurodegeneration | 2026-04-26 | 8 hypotheses Top: 0.861

Does pericyte senescence drive BBB breakdown or result from neurodegeneration as

neurodegeneration | 2026-04-25 | 6 hypotheses Top: 0.720

Survival Analysis of AD Patient Cohorts: Prognostic Markers and Time-to-Dementia

neurodegeneration | 2026-04-16 | 3 hypotheses Top: 0.895

Multi-modal Biomarker Panel Design for Early AD Detection

neurodegeneration | 2026-04-16 | 1 hypotheses Top: 0.579

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (14)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Increased Neuronal Expression of the Early Endosomal Adaptor APPL1 Replicates Al [PMID:40514243] Jiang Y, Sachdeva K, Goulbourne CN, Berg The Journal of neuroscience : 2025 0
P-tau217 correlates with neurodegeneration in Alzheimer's disease, and targeting [PMID:38513667] Zhang D, Zhang W, Ming C, Gao X, Yuan H, Neuron 2024 0
The necroptosis cell death pathway drives neurodegeneration in Alzheimer's disea [PMID:38852117] Balusu S, De Strooper B Acta neuropathologica 2024 0
Chemical genetic activation of the cholinergic basal forebrain hippocampal circu [PMID:35418161] Weilin Liu, Jianhong Li, Minguang Yang {'name': "Alzheimer's Research 2022 0
Memorable Food: Fighting Age-Related Neurodegeneration by Precision Nutrition. [PMID:34422879] ["Milo\u0161evi\u0107 M", "Arsi\u0107 A" Frontiers in nutrition 2021 0
Insulin Resistance and Diabetes Mellitus in Alzheimer's Disease. [PMID:34069890] Burillo J, Marqués P, Jiménez B, Gonzále Cells 2021 0
Genetic deletion of trpa1 receptor attenuates amyloid beta- 1-42 (aβ1-42)-induce [PMID:32473171] Maja Payrits, Éva Borbély, Soma Godo {'name': 'Mechanisms of ageing 2020 0
Implications of Oligomeric Amyloid-Beta (oAβ42) Signaling through α7β2-Nicotinic [PMID:33239400] Andrew A. George, Jaime M. Vieira, Camer {'name': 'The Journal of Neuro 2020 0
Removal of p75 Neurotrophin Receptor Expression from Cholinergic Basal Forebrain [PMID:30374941] Lei Qian, M. Milne, Stephanie R Shephear {'name': 'Molecular Neurobiolo 2018 0
Dietary DHA and health: cognitive function ageing. [PMID:27866493] Unknown Nutr Res Rev 2016 0
Docosahexaenoic acid and synaptic protection in Alzheimer's disease mice. [PMID:20211757] Unknown Biochim Biophys Acta 2010 0
Survival signalling in Alzheimer's disease. [PMID:17073801] Unknown Biochem Soc Trans 2006 0
Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in tra [PMID:17021169] ["Oakley, Holly", "Cole, Sarah L", "Loga The Journal of neuroscience : 2006 0
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road [PMID:12130773] ["Hardy, John", "Selkoe, Dennis J"] Science (New York, N.Y.) 2002 0

Debates (20)

Multi-agent debates referencing this entity

Second debate: Microglial TREM2-SYK Pathway Enhancement

closed · Rounds: 4 · Score: 0.57 · 2026-04-28

Extended debate: TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegenera

closed · Rounds: 6 · Score: 0.95 · 2026-04-27

Extended debate: Closed-loop transcranial focused ultrasound with 40Hz gamma ent

closed · Rounds: 6 · Score: 0.95 · 2026-04-27

Extended debate: Closed-loop tACS targeting EC-II SST interneurons to block tau

closed · Rounds: 6 · Score: 0.95 · 2026-04-27

Debate: Closed-loop transcranial focused ultrasound targeting entorhinal PV inte

closed · Rounds: 4 · Score: 0.65 · 2026-04-27

Debate: Closed-loop tACS targeting EC-II SST interneurons to block tau propagati

closed · Rounds: 4 · Score: 0.71 · 2026-04-27

Debate: Closed-loop transcranial focused ultrasound to restore hippocampal gamma

closed · Rounds: 4 · Score: 0.87 · 2026-04-27

Debate: Closed-loop tACS targeting EC-II PV interneurons to suppress burst firin

closed · Rounds: 4 · Score: 0.48 · 2026-04-27

Debate: LPCAT3-Mediated Lands Cycle Remodeling as the Primary Ferroptotic Primin

closed · Rounds: 4 · Score: 0.12 · 2026-04-27

Debate: ALOX15-Driven Enzymatic Ferroptosis in AD Oligodendrocytes via PUFA-PE P

closed · Rounds: 4 · Score: 0.42 · 2026-04-27

Related Research

Hypotheses and analyses mentioning in their description or question text

Soluble LRP1 (sLRP1) Ectodomain Shedding as a Blood-Based Indicator of Impaired

Score: 0.680 · unknown disease · 2026-04-26

LRP1 mediates Aβ export from brain to blood at the BBB. Metalloprotease-mediated shedding of the LRP1 ectodomain (sLRP1)

Gamma entrainment enhances TREM2-mediated microglial clearance of Aβ plaques via

Score: 0.678 · alzheimers · 2026-04-28

40 Hz neural activity induces Ca2+ oscillations in microglia through P2X7 receptor activation, promoting TREM2 phosphory

Fyn-anchored dendritic tau/NMDAR signaling persists after transient Aβ exposure

Score: 0.670 · neurodegeneration · 2026-04-25

Aβ drives tau into dendritic spines, where tau binds Fyn and stabilizes a PSD95-NMDAR-associated excitotoxic scaffold. O

PDGF-BB/PDGFRβ/STAT3 Paracrine Signaling Axis Mediates Aβ-Induced SPP1 Upregulat

Score: 0.618 · neurodegeneration · 2026-04-22

**Molecular Mechanism and Rationale** The proposed PDGF-BB/PDGFRβ/STAT3 signaling axis represents a complex intercellul

LRP1/NLRP3/IL-1β Cascade Links Aβ Endocytosis to Inflammasome Activation and SPP

Score: 0.617 · neurodegeneration · 2026-04-22

**Molecular Mechanism and Rationale** The proposed LRP1/NLRP3/IL-1β cascade represents a critical mechanistic link betw

Aβ42 oligomers drive TDP-43 phosphorylation at s409/410 through CDK5/p25 activat

Score: 0.595 · neurodegeneration · 2026-04-21

**Molecular Mechanism and Rationale** The hypothesis centers on a novel mechanistic pathway linking amyloid-β42 (Aβ42)

Aβ-induced downregulation of circPDS5B derepresses TDP-43 mRNA translation in li

Score: 0.595 · neurodegeneration · 2026-04-21

**Molecular Mechanism and Rationale** The proposed mechanism centers on a complex regulatory network involving circPDS5

Closed-Loop Phase-Specific Targeting of PV-to-Pyramidal Synapses Corrects Aβ-Ind

Score: 0.585 · alzheimers · 2026-04-28

Aβ 1-42 selectively depresses excitatory synaptic inputs onto PV interneurons via NMDA receptor subunit changes (GluN2B/

Neuropeptide Y (NPY) Co-release from PV Interneurons Modulates Aβ Toxicity

Score: 0.585 · alzheimers · 2026-04-28

PV interneurons co-release NPY, which signals via Y1 receptors on excitatory terminals to suppress glutamate release and

Astrocyte-PV Interneuron Metabolic Coupling as a Mediator of Aβ Vulnerability

Score: 0.565 · alzheimers · 2026-04-28

PV interneurons exhibit heightened metabolic demand during gamma oscillations. Aβ impairs astrocytic lactate shuttling (

HBOT (2.0 ATA, 60 min) activates TFEB-mediated autophagy-lysosome pathway to acc

Score: 0.560 · neurodegeneration · 2026-04-25

HBOT increases mTORC1 inhibition, promoting TFEB nuclear translocation and enhancing autophagy flux to clear pathologica

CYP46A1 Activation as a Therapeutic Strategy to Restore Neuronal Cholesterol Eff

Score: 0.550 · lipidomics · 2026-04-25

CYP46A1 Activation as a Therapeutic Strategy to Restore Neuronal Cholesterol Efflux and Reduce Aβ Production

Cross-Seeding: Gut Microbiome-Derived Bacterial Curli and Fungal Amyloid Synergi

Score: 0.540 · neurodegeneration · 2026-04-26

Commensal bacteria (E. coli, Salmonella) produce curli amyloid fibers encoded by the csg operon, while Candida and Sacch

CD36 Acts as Primary Aβ Oligomer Sensor on Perivascular Macrophages, Triggering

Score: 0.535 · neurodegeneration · 2026-04-22

## Mechanistic Overview CD36 Acts as Primary Aβ Oligomer Sensor on Perivascular Macrophages, Triggering NF-κB-Dependent